Výsledky vyhledávání - Sebastian Stintzing
- Zobrazuji výsledky 1 - 20 z 42
- Přejít na další stránku
-
1
Management of colorectal cancer Autor Sebastian Stintzing
Vydáno 2014Revisão -
2
-
3
-
4
-
5
-
6
-
7
-
8
Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer Autor Alexander Sebastian Franzén, Abdelhadi Boulifa, Clarissa Radecke, Sebastian Stintzing, Martin Raftery, Gabriele Pecher
Vydáno 2024Artigo -
9
Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer Autor Jörg Trojan, Sebastian Stintzing, Oliver Haase, Christine Koch, Paul Ziegler, Melanie Demes, Ivan Jelas
Vydáno 2021Artigo -
10
-
11
-
12
-
13
Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in Metastatic Colorectal Cancer: Literature-Based Analysis from 50 Randomized First-Line Trials Autor Clemens Gießen, Ruediger P. Laubender, Donna P. Ankerst, Sebastian Stintzing, Dominik Paul Modest, Ulrich Mansmann, Volker Heinemann
Vydáno 2012Revisão -
14
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AI... Autor Dominik Paul Modest, Ruediger P. Laubender, Sebastian Stintzing, Clemens Gießen, Christoph Schulz, Michael Haas, Ulrich Mansmann, Volker Heinemann
Vydáno 2012Artigo -
15
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type me... Autor Volker Heinemann, Fernando Rivera, Bert H. O’Neil, Sebastian Stintzing, Reija Koukakis, Jan-Henrik Terwey, Jean‐Yves Douillard
Vydáno 2016Revisão -
16
Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer Autor Martin Raftery, Alexander Sebastian Franzén, Clarissa Radecke, Abdelhadi Boulifa, Günther Schönrich, Sebastian Stintzing, Jens‐Uwe Blohmer, Gabriele Pecher
Vydáno 2023Artigo -
17
Prognostic and Predictive Relevance of Primary Tumor Location in Patients With <i>RAS </i>Wild-Type Metastatic Colorectal Cancer Autor Sabine Tejpar, Sebastian Stintzing, Fortunato Ciardiello, Josep Tabernero, Eric Van Cutsem, Frank Beier, Regina Esser, Heinz‐Josef Lenz, Volker Heinemann
Vydáno 2016Artigo -
18
Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer Autor Richard M. Goldberg, Clara Montagut, Zev A. Wainberg, Philippe Ronga, Françis Audhuy, Julien Taı̈eb, Sebastian Stintzing, Salvatore Siena, Daniele Santini
Vydáno 2018Revisão -
19
Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial Autor Clemens Gießen, Ruediger P. Laubender, Ludwig Fischer von Weikersthal, Andreas Schalhorn, Dominik Paul Modest, Sebastian Stintzing, Michael Haas, Ulrich Mansmann, Volker Heinemann
Vydáno 2013Artigo -
20
Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal tran... Autor Sebastian Stintzing, Christine Kapaun, Rüdiger P. Laubender, Andreas Jung, Jens Neumann, Dominik Paul Modest, Clemens Gießen, Nicolas Moosmann, Andreas Wollenberg, Thomas Kirchner, Volker Heinemann
Vydáno 2012Artigo
Vyhledávací nástroje:
Související témata
Cancer
Internal medicine
Medicine
Colorectal cancer
Oncology
Cetuximab
Chemotherapy
Cancer research
Irinotecan
Bevacizumab
KRAS
Biology
Biochemistry
FOLFIRI
Immunotherapy
Oxaliplatin
Confidence interval
Epidermal growth factor receptor
Hazard ratio
Immunology
Randomized controlled trial
Surgery
Environmental health
Gene
Immune system
Population
Clinical endpoint
Chemistry
Clinical trial
Gastroenterology